MIT Solve

Solution overview

Our Solution

VideoOculograph

Tagline

World’s most accurate & effective technology of eye pathologies diagnostics & noninvasive treatment

Pitch us on your solution

There are tens of thousands of patients with nystagmus in each average country, 7% of children and 4% of total adult population all over the world suffering from strabismus. Treatment of nystagmus and strabismus is still in 95% of cases performed only by surgery, same time defect of nystagmus according to statistics can return in 6 -12 months even after successful surgery while lack of treatment leads to loss of vision.

VideoOculograph allows to solve this problem just simply by programmable light stimulation with no surgical risks or further long rehabilitation period.

We've developed 1st complex intelligent device for diagnostics by eye moves and pupils' reaction and noninvasive vision pathologies correction.

Technology was scientifically validated on base of leading clinics including Fedorov network medical clinic with more than 300 successfully treated patients in a result.

Thus, it's revolutionary technology which forever will improve people' health overall as well.

Film your elevator pitch

What is the problem you are solving?

There are tens of thousands of patients with nystagmus in each average country, 7% of children and 4% of total adult population all over the world suffering from strabismus. Treatment of nystagmus and strabismus is still in 95% of cases performed only by surgery, same time defect of nystagmus according to statistics can return in 6 -12 months even after successful surgery while lack of treatment leads to loss of vision.

Our team believes that everyone should have access to highest level of health care experience possible, so we formed VideoOculograph with one mission: to redefine the way we used to conduct health diagnostics and vision pathologies treatment, bring revolution in health diagnostic and vision treatment, make Personal Healthcare Concept a reality.

And now high reliable diagnostics exam by eyes is now obtainable where you need it and any time you want. You can even test someone from any point of the world. For this it's just enough to upload to device, app. or VideoOculograph interactive platform the eyes' video from at least 120 fps camera. One can heal from such eye pathologies as nystagmus or strabismus without just simply by the light. No surgery risks or rehabilitation period.

Who are you serving?

There are tens of thousands of patients with nystagmus in each average country, 7% of children and 4% of total adult population all over the world suffering from strabismus. Treatment of nystagmus and strabismus is still in 95% of cases performed only by surgery, same time defect of nystagmus according to statistics can return in 6 -12 months even after successful surgery while lack of treatment leads to loss of vision.

VideoOculograph allows to solve this problem just simply by programmable light stimulation with no surgical risks or further long rehabilitation period.

Our technology's been already scientifically validated on base of leading clinics including Fedorov network medical clinic ISTC «Eye microsurgery» with more than 300 successfully treated patients with nystagmus in a result.

The worldwide promotion of product is planned: the product is launched in Russia and CIS countries markets and preparing for further launch abroad starting from Switzerland, Germany and Denmark, USA and China. Our goal is at least 200 european clinics up to 2020 year.

What is your solution?

VideoOculograph - 1st complex intelligent solution on base of AI, computer vision and machine learning for reliable diagnostics of several diseases (vision pathologies, neurological disorders, inner ear illnesses etc.) by involuntary eye moves and pupils' reaction and noninvasive treatment of eye pathologies if such were revealed.

VideoOculograph can be used for:
 Diagnostics and noninvasive treatment of eye pathologies
 Diagnostics of neurological disorders, inner ear illnesses and others
 Narcotic and alcoholic intoxication exam by pupils' reaction
 Lie detection by involuntary eye movements

VideoOculograph is automatic and easy to operate with: simply put it on, choose the diagnostic algorithm and press the start button. The protocol with diagnostic data is available even on your PC, touch pad, or smartphone through VideoOculograph mobile app already within 5 min. One can use VideoOculograph to analyze and track trends, catch changes early with unprecedented simplicity for not to let precious diagnostic data get lost.

Thus high reliable diagnostics exam of several diseases by eyes is now obtainable where you need it and any time you want. You can even test someone from any point of the world. For this it's just enough to upload to device, app. or VideoOculograph interactive platform the eyes' video from at least 120 fps camera.

One can begin the treatment procedure when ready if eye pathology was revealed, heal from such eye pathologies as nystagmus or strabismus without any surgery just simply by the light. No surgery risks or rehabilitaion period at all.

VideoOculograph also includes functional of lie detector by involuntary eye moves - parameter which can’t be controlled intentionally, with an accuracy up to 99,8% in comparison with standard polygraph with accuracy only up to 65-80%, and allows to reveal narcotic and alcoholic intoxication by pupils' reaction instead of the standard urine drug test.

The researchers, conducted on base of Internal Affairs Ministry of Russian Federation, Federal Penitentiary Service of Saratov Region, and Chair of Narcology and Psychiatry of Razumovskiy Saratov State Medical University, proved its effectiveness.

Thus, it's revolutionary technology which forever will change the way we used to conduct vision diagnostics and treatment and will improve people' health overall as well.

Which dimensions of the challenge does your solution most closely address?

Enable equitable access to affordable and effective health services

Where is your solution team headquartered?

Moscow, Russia

Our solution's stage of development:

Pilot

More about your solution

Select one of the below:

New technology

Describe what makes your solution innovative.

In addition to surgery correction for noninvasive treatment of nystagmus and strabismus russian product - Monobinoscope MBS-02 FORBIS (http://www.med-snab.ru/shop/part13/oftalmomiotrenazhery/monobinoskop-mbs-02/) is known. It's cost is $4150, weigh is about 20 kg. However it does not allow to conduct online high accurate computer video diagnostics of eye pathologies during the the procedures for accurate treatment effectiveness tracking and doesn't assume keeping of video base of diagnostics data of patients and machine learning approaches' using.

There are analog diagnostics systems from companies of international William Demant Holding. The nearest portable solution from one of them, Interacoustics VNG VO425 (http://www.interacoustics.com/vng), for 7780$ doesn’t allow to conduct the noninvasive correction of eye pathologies but intended only for nystagmus' diagnostics.

Thus our value proposal for target audience is 1st portable inteligent solution which allows to to do both: high reliable health diagnostics by eye moves' and pupils' reaction and noninvasive vision correction in case if needed as well with an opportunity of online accurate treatment effectiveness tracking right during the treatment procedures.

Describe the core technology that your solution utilizes.

We've developed the 1st complex intelligent solution on base of AI, computer vision and machine learning for reliable diagnostics of several diseases (vision pathologies, neurological disorders, inner ear illnesses etc.) by involuntary eye moves and pupils' reaction and noninvasive treatment of eye pathologies if such were revealed.

VideoOculograph can be used for:

 Diagnostics and noninvasive treatment of eye pathologies

 Diagnostics of neurological disorders, inner ear illnesses and others

 Narcotic and alcoholic intoxication exam by pupils' reaction

 Lie detection by involuntary eye movements

VideoOculograph is automatic and easy to operate with: simply put it on, choose the diagnostic algorithm and press the start button. The protocol with diagnostic data is available even on your PC, touch pad, or smartphone through VideoOculograph mobile app already within 5 min. One can use VideoOculograph to analyze and track trends, catch changes early with unprecedented simplicity for not to let precious diagnostic data get lost.

Thus high reliable diagnostics exam of several diseases by eyes is now obtainable where you need it and any time you want. You can even test someone from any point of the world. For this it's just enough to upload to device, app. or VideoOculograph interactive platform the eyes' video from at least 120 fps camera.

One can begin the treatment procedure when ready if eye pathology was revealed, heal from such eye pathologies as nystagmus or strabismus without any surgery just simply by the light. No surgery risks or rehabilitaion period at all.

Please select the technologies currently used in your solution:

Artificial Intelligence
Machine Learning

Why do you expect your solution to address the problem?

We've developed the 1st complex intelligent solution on base of AI, computer vision and machine learning which allows to do both: high reliable diagnostics of several diseases (vision pathologies, neurological disorders, inner ear illnesses etc.) by involuntary eye moves and pupils' reaction and noninvasive treatment of eye pathologies if such were revealed same time while treatment of nystagmus and strabismus at the same time is still in 95% of cases performed only by surgery, well-known techniques of preoperative registration based on electrooculography or photoelectric nystagmography don’t give reliable quantitative data, same time defect of nystagmus according to statistics can return in 6 -12 months even after successful surgery while lack of treatment leads to loss of visual acuity up to blindness.

Now technology was scientifically validated during trials on base of leading clinics including Fedorov network medical clinic ISTC «Eye microsurgery» with more than 300 successfully treated patients with nystagmus in a result. Control exams're carried out in 6 and 12 months.

Currently we're growing: we've doubled our half year profit since the last 6 months. Our customers - leading Russian network medical clinics. One of our key customers and partner is famous Fedorov ophthalmic centre «Eye microsurgery».

We also raised some funding all equity free such as $30K Grant from FASIE Fund last month, found new distributors both inside and outside of Russia and won several international contests and state awards.

Select the key characteristics of the population your solution serves.

Children and Adolescents
Persons with Disabilities

In which countries do you currently operate?

Denmark
Germany
Switzerland
Belarus
Kazakhstan
Russian Federation
Ukraine

In which countries will you be operating within the next year?

Denmark
Germany
Switzerland
Belarus
Kazakhstan
Russian Federation
Ukraine

How many people are you currently serving with your solution? How many will you be serving in one year? How about in five years?

Now our technology was scientifically validated during trials on base of leading clinics including Fedorov network medical clinic ISTC «Eye microsurgery» with more than 300 successfully treated patients with nystagmus in a result.

We've shiped our solution to 9 network medical clinics.

Our goal is at least 70 European clinics next year and 500 clinics in 5 years.

What are your goals within the next year and within the next five years?

Our goal is to help educate the world on the potential of how VideoOculograph technology can help to improve people' health and their life quality, make their lives happier, healthier, and easier—every day.

The worldwide promotion of product is planned: the product is launched in Russia and CIS countries markets and preparing for further launch abroad starting from Switzerland, Germany and Denmark, USA and China.

Target audience:

• Distributors of diagnostic equipment & health products: licenses sales, hardware & software complexes sales (margin profit from 45%), software sales

• Network medical clinics, state and private health facilities: hardware & software complexes sales (margin profit from 45%)

• Networks of consumer electronics: hardware & software complexes sales (margin profit: 100%)

• Research institutes in Russia and abroad

• Medical associations (ISTC "Eye microsurgery", All-Russian Ophthalmological Society etc.)

• Enforcement authorities

• Direct customers: hardware&software complexes sales, remote diagnostics services

Business model includes opportunity of sale of license to distributor or company's equity to investor, one of key competitors such as William Demant Holding or major international manufacturer (Carl Zeiss, Alcon, J&J, Philips, Sanofi, Huawei etc.) or strategic partner.

What are the barriers that currently exist for you to accomplish your goals for the next year and for the next five years?

To bring the VideoOculograph to the vast consumer market including USA, we still have to file with the FDA while the exploratory version of the VideoOculograph is not a medical device yet for USA market and makes no medical claims, it can only be used as part of an investigation for collecting certain data in accordance with the study’s protocol.

How are you planning to overcome these barriers?

Before VideoOculograph can become a medical device for USA market it will have to go through the FDA (Food and Drug Administration) premarket notification process. VideoOculograph eligible participants will help us by testing themself as part of a research study and giving us feedback to refine the VideoOculograph. This will happen in the framework of official clinical studies. This way we can put VideoOculograph through FDA to become an over-the-counter consumer-grade diagnostic tool.

If your solution has a website, provide a link here:

http://videooculograph.ru/

If your solution proposes an app that is available, provide a link to your app online or in an app store here:

https://youtu.be/9SUY-thm_fI

If you have additional video, provide a YouTube or Vimeo link to your video here:

About your team

Select an option below:

For-profit

If you selected Other for the organization question, please explain here.

N/A

How many people work on your solution team?

Our team is 7 peaople right now. The founders of company are we with my sister with 50/50 equity split. We earlier worked together on the startup and sold our previous business to our strategic investor from Seoul.

VideoOculoraph team is comprised of MDs: surgeons-ophtalmologists and biophysicists, data scientists, mathematicians and coders, mechanical and electrical engineers. Two our key technology developers are well known surgeons-ophthalmologists with more than 30 years of surgical practice and successful inventions in healthcare industry with relevant expertise in field of development of Hardware&Software complexes for medical diagnostics.

For how many years have you been working on your solution?

2 years

Why are you and your team best-placed to deliver this solution?

After working in ophtalmology and healthcare for a combined seventy years, developing some of the top distributed in Russia in CIS countries diagnostic solutions for vision, our founding team realized that there was a large gap in what was currently available for eye pathologies diagnostic and noninvasive treatment, and what was possible. Our team believed that everyone should have access to the highest level of healtch care experience possible, so we formed VideoOculograph with one mission: to redefine the way we used to conduct health diagnostics and vision pathologies treatment, bring revolution in health diagnostic and vision treatment. This'll make Personal Healthcare Concept a reality!

With what organizations are you currently partnering, if any? How are you working with them?

Now our technology was scientifically validated during trials on base of leading clinics including Fedorov network medical clinic ISTC «Eye microsurgery» with more than 300 successfully treated patients with nystagmus in a result.

Our Partners:
R&D Partner:
• Chernishevskiy National research Saratov State University (http://sgu.ru/)
Clinical Trials Partners:
• Fedorov Interbranch Scientific & Technical Complex «Eye microsurgery» (http://www.mntk.ru/)
• Clinic of Eye Diseases of Razumovskiy Saratov State Medical University (http://eyeclinicsgmu.ru/)
• Helmholtz Moscow Research Institute of Eye Diseases (http://helmholtzeyeinstitute.ru/)
Media Partner:
• All-Russian Society of Inventors & Rationalizes (http://www.ros-voir.ru/)
Industrial Partner:
• Shvabe (http://shvabe.com/en/about/)
Funding Partner:
• Federal Fund for Assistance to Small Innovative Enterprises in Science and Technology (http://fasie.ru/)

Your business model & funding

Partnership potential

Why are you applying to Solve?

Our goal is to help educate the world on the potential of how VideoOculograph technology can help to improve people' health and their life quality, make their lives happier, healthier, and easier—every day. To do this, we need to get the word out about what we’re developing so Solveris a good chance to make it faster - make the revolutionary in healthcare and make the Personal Healhcare Concept a reality.

What types of connections and partnerships would be most catalytic for your solution?

Distribution
Funding and revenue model
Media and speaking opportunities

If you selected Other, please explain here.

N/A

With what organizations would you like to partner, and how would you like to partner with them?

Sanofi, Huawei, J&J, Philips

If you would like to apply for the AI Innovations Prize, describe how you and your team will utilize the prize to advance your solution. If you are not already using AI in your solution, explain why it is necessary for your solution to be successful and how you plan to incorporate it.

If our team will be selected the prize will be 100% invested on further R&D (mobile configuration optimization and interactive platform automatization), IP rights protection, CE and FDA certification, production, and further launch and market promotion to bring to the market world’s most reliable & effective technology of pathologies diagnostics & noninvasive vision correction. on base of AI, computer vision and machine learning in shortest time possible.

IP Rights Protection Plan:

Already protected for Russia, PCT localization in Europe (Germany, Denmark, Switzerland), USA, China up to 2021st year

R&D Plan:

• Development and launch of portable configuration with video glasses
• Launch of IOS and Android Apps for online diagnostics
• Launch of interactive platform for remote online diagnosticsCertification:
• Current configuration with module for vision pathologies correction was certified for RU certification GOST50444-92, GOST 20790-93, GOST 50267.0-92, GOST50267.0.2-95
• Certification of new configuration in 19thyear
• Certification CE and FDA up to 2021styear

If you would like to apply for the Innovating Together for Healthy Cities Prize, describe how you and your team will utilize the prize to advance your solution.

If our team will be selected the prize will be 100% invested on further R&D (mobile configuration optimization and interactive platform automatization), IP rights protection, CE and FDA certification, production, and further launch and market promotion to bring to the market world’s most reliable & effective technology of pathologies diagnostics & noninvasive vision correction. on base of AI, computer vision and machine learning in shortest time possible.

IP Rights Protection Plan:

Already protected for Russia, PCT localization in Europe (Germany, Denmark, Switzerland), USA, China up to 2021st year

R&D Plan:

• Development and launch of portable configuration with video glasses • Launch of IOS and Android Apps for online diagnostics • Launch of interactive platform for remote online diagnosticsCertification: • Current configuration with module for vision pathologies correction was certified for RU certification GOST50444-92, GOST 20790-93, GOST 50267.0-92, GOST50267.0.2-95 • Certification of new configuration in 19thyear • Certification CE and FDA up to 2021styear

If you would like to apply for the Everytown for Gun Safety Prize, describe how you and your team will utilize the prize to advance your solution.

N/A

If you would like to apply for the Innovation for Women Prize, describe how you and your team will utilize the prize to advance your solution.

N/A

If you would like to apply for the Innospark Ventures Prize, describe how you and your team will utilize the prize to advance your solution. If your solution utilizes data, describe how you will ensure that the data is sourced, maintained, and used ethically and responsibly.

If our team will be selected the prize will be 100% invested on further R&D (mobile configuration optimization and interactive platform automatization), IP rights protection, CE and FDA certification, production, and further launch and market promotion to bring to the market world’s most reliable & effective technology of pathologies diagnostics & noninvasive vision correction. on base of AI, computer vision and machine learning in shortest time possible.

IP Rights Protection Plan:

Already protected for Russia, PCT localization in Europe (Germany, Denmark, Switzerland), USA, China up to 2021st year

R&D Plan:

• Development and launch of portable configuration with video glasses • Launch of IOS and Android Apps for online diagnostics • Launch of interactive platform for remote online diagnosticsCertification: • Current configuration with module for vision pathologies correction was certified for RU certification GOST50444-92, GOST 20790-93, GOST 50267.0-92, GOST50267.0.2-95 • Certification of new configuration in 19thyear • Certification CE and FDA up to 2021styear

If you would like to apply for the UN Women She Innovates Prize for Gender-Responsive Innovation, describe how you and your team will utilize the prize to advance your solution.

The founders of VideoOculograph are we with my sister, Anastasiya Usanova, and our key technology developer and Medical Director is our mom, Tatiyana Usanova, famous russian surgeon-ophtalmologist with more than 30 years of surgical practice and successful inventions in healthcare industry with relevant expertise in field of development of Hardware&Software complexes for medical diagnostics.

If our team will be selected the prize will be 100% invested on further R&D (mobile configuration optimization and interactive platform automatization), IP rights protection, CE and FDA certification, production, and further launch and market promotion to bring to the market world’s most reliable & effective technology of pathologies diagnostics & noninvasive vision correction. on base of AI, computer vision and machine learning in shortest time possible.

IP Rights Protection Plan:

Already protected for Russia, PCT localization in Europe (Germany, Denmark, Switzerland), USA, China up to 2021st year

R&D Plan:

• Development and launch of portable configuration with video glasses • Launch of IOS and Android Apps for online diagnostics • Launch of interactive platform for remote online diagnosticsCertification: • Current configuration with module for vision pathologies correction was certified for RU certification GOST50444-92, GOST 20790-93, GOST 50267.0-92, GOST50267.0.2-95 • Certification of new configuration in 19thyear • Certification CE and FDA up to 2021styear